Catalyst
Slingshot members are tracking this event:
DBV Tech (DBVT) Completes Enrollment for Phase 2b MILES Study Evaluating Viaskin Milk for Patients Ages 2-17 with IgE-mediated Cow's Milk Protein Allergy (CMPA)
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| DBVT |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 08, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Enrollment, Phase 2b, Miles, Viaskin Milk, Ige-mediated, Cow's Milk Protein Allergy, Cmpa
